The global demand for Artificial Saliva Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Artificial Saliva is a chemical product produced in the labs to resemble natural saliva in its functions and is used to treat a condition called dry mouth. This is generally used by people who suffer from salivary gland dysfunction or certain medical conditions like Alzheimer's, stroke. This condition causes reduced secretion as well as changes in the composition of saliva. The various issues associated with dry mouth are increased tooth decay and gum disease, inflammation that can cause infection and bad breath. Dry mouth can make chewing, swallowing and speaking quite difficult. Saliva is a secretion produced by a gland in the mouth and is a critical element needed for proper digestion of the food. Since a lack of required quantity and expected quality of saliva in the mouth can lead to serious health problems, a substitute is required to maintain the microbial, rheological and lubrication properties of natural saliva. Artificial saliva is generally in the form of a liquid and also has some side effects.
Market Dynamics
The artificial saliva market is consumer-based and hence an increase in disposable income and per-capita will greatly benefit in the growth of this market. The growing geriatric population in certain geographical areas can be a blessing in disguise for the artificial saliva market. The growth of this market can be restrained by the number of alternatives available to treat a dry mouth such as acupuncture, medicines made using herbs and artificial stimulants. An increase in R&D activity to deliver artificial salivary glands can hamper the prospects of the artificial saliva market.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of artificial saliva.
Market Segmentation
The entire artificial saliva market has been sub-categorized into product type, age group, and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product Type
- Oral Spray
- Oral Solution
- Oral Liquid
- Gel
- Powder
By Age Group
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
- Hypermarkets and Supermarkets
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for artificial saliva market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Artificial Saliva Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial saliva market include GlaxoSmithKline plc, Cipla Limited, Mission Pharmacal Company, Fresenius Kabi, Parnell Pharmaceuticals, Inc., CCMed Group, Entod International, Midatech Pharma Plc, Forward Science, Valeant Pharmaceuticals International, Inc., Biocosmetics Laboratories, Icpa Health Products LTD., Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
